OSSIO
U.S. Launch and First Commercial Use of the OSSIOfiber® Trimmable Fixation Nail System Reported
U.S. launch and first commercial use of the OSSIOfiber® Trimmable Fixation Nail System to securely fixate bone...
OSSIO
OSSIO Announces U.S. Launch and First Commercial Use of the OSSIOfiber® Trimmable Fixation Nail System for Broad Utilization in Foot/Ankle and Hand/Wrist Procedures
Part of the OSSIOfiber® Bone Pin Product Family, which received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) in 2019, the OSSIOfiber® Trimmable Fixation Nail System includes strong, biointegrative Trimmable Fixation Nails in 2.4mm and 4.0mm diameters packaged with corresponding sterile, disposable instrumentation.
OSSIO
OSSIO Secures $22 Million in Financing
3/11/19: OSSIO has raised a total of $35 million to date. The Company will use these funds to accelerate strategic growth initiatives, including talent acquisition, commercialization, new product development and operational expansion.
OSSIO
OSSIO Receives FDA 510(k) Clearance for OSSIOfiber™ Bone Pin Product Family
1/14/19: New bio-integrative orthopedic fixation material provides unprecedented combination of mechanical strength and natural bone healing in a non-permanent implant.
